Treatment with denosumab reduces secondary fracture risk in women with postmenopausal osteoporosis-Reference-Cited by-同舟云学术

Treatment with denosumab reduces secondary fracture risk in women with postmenopausal osteoporosis

Published:2015-09-28 Issue:6 Volume:18 Page:805-812
ISSN:1369-7137
Container-title:Climacteric
language:en
Short-container-title:Climacteric

Author:

Palacios S.,Kalouche-Khalil L.,Rizzoli R.,Zapalowski C.,Resch H.,Adachi J. D.,Gallagher J. C.,Feldman R. G.,Kendler D. L.,Wang A.,Wagman R. B.,Adami S.

Publisher

Informa UK Limited

Subject

Obstetrics and Gynecology,General Medicine

Link

http://www.tandfonline.com/doi/pdf/10.3109/13697137.2015.1045484

Reference44 articles.

1. Osteoporosis: burden, health care provision and opportunities in the EU

2. Fragility Fractures and the Osteoporosis Care Gap: An International Phenomenon

3. A meta-analysis of previous fracture and subsequent fracture risk

4. Patients with Prior Fractures Have an Increased Risk of Future Fractures: A Summary of the Literature and Statistical Synthesis

5. The Importance of Previous Fracture Site on Osteoporosis Diagnosis and Incident Fractures in Women

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Real‐world Study of Denosumab For Reducing Refracture Risk after Percutaneous Vertebral Augmentation;Orthopaedic Surgery;2024-07

2. Molecular landscape of prostate cancer bone metastasis;Advances in Cancer Research;2024

3. Approach to the Patient With Bone Fracture: Making the First Fracture the Last;The Journal of Clinical Endocrinology & Metabolism;2023-06-08

4. Fracture risk reduction and safety by osteoporosis treatment compared with placebo or active comparator in postmenopausal women: systematic review, network meta-analysis, and meta-regression analysis of randomised clinical trials;BMJ;2023-05-02

5. Executive summary: Italian guidelines for diagnosis, risk stratification, and care continuity of fragility fractures 2021;Frontiers in Endocrinology;2023-04-18